文献速递神经MR

髓鞘少突胶质细胞糖蛋白免疫球蛋白G抗体相关疾病中的类淋巴系统功能障碍:与临床残疾的关联

Glymphatic System Dysfunction in Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disorders: Association with Clinical Disability.
PubMed 文献 · AJNR Am J Neuroradiol · 2023-12-29

前瞻性研究纳入16例缓解期MOGAD患者与22名年龄性别匹配健康对照,用3T扩散MRI计算ALPS指数;患者平均ALPS指数显著低于对照(Cohen d=0.93,FDR校正P=.02),且较低ALPS指数与较差EDSS评分相关(Spearman ρ=-0.51;95%CI -0.85至-0.02;P=.03),而灰质体积两组无显著差异且与EDSS无关。

要点

  • MOGAD患者平均ALPS指数显著低于健康对照(Cohen d=0.93,FDR校正P=.02)。
  • 较低ALPS指数与较差EDSS评分相关(Spearman ρ=-0.51;95%CI -0.85至-0.02;P=.03)。
  • 皮质体积与深部灰质体积两组无显著差异,且与EDSS无相关。

核心结论

  • 本研究提示MOGAD患者可能存在以ALPS指数测得的类淋巴功能受损,且该指数与患者残疾相关;原文指出需更大样本量进一步研究。

研究设计与样本

  • 前瞻性研究,纳入16例缓解期MOGAD患者与22名年龄、性别匹配的健康对照,使用3T扫描仪行MRI,以b值1000 s/mm2的扩散MRI数据计算ALPS指数。

诊断标准与关键数值

  • 以b值1000 s/mm2扩散MRI数据计算ALPS指数。
  • MOGAD患者平均ALPS指数显著低于健康对照(Cohen d=0.93,FDR校正P=.02)。
  • 较低平均ALPS指数与较差EDSS评分显著相关(Spearman ρ=-0.51;95%CI -0.85至-0.02;P=.03)。
  • 皮质体积与深部灰质体积两组无显著差异,且与EDSS无相关。

局限性

  • 原文指出需更大样本量进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Impaired glymphatic function has been suggested to be implicated in the pathophysiology of MS and aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder. This study aimed to investigate the interstitial fluid dynamics in the brain in patients with myelin oligodendrocyte glycoprotein antibody disorders (MOGAD), another demyelinating disorder, using a noninvasive imaging technique called the diffusivity along the perivascular space (ALPS) index.

MATERIALS AND METHODS: A prospective study was conducted on 16 patients with MOGAD in remission and 22 age- and sex-matched healthy control subjects. MR imaging was performed using a 3T scanner, and the ALPS index was calculated using diffusion MR imaging data with a b-value of 1000 s/mm2. The ALPS index and gray matter volumes were compared between the 2 groups, and these parameters were correlated with the Expanded Disability Status Scale.

RESULTS: The mean ALPS index of patients with MOGAD was significantly lower than that of healthy controls (Cohen d = 0.93, false discovery rate-corrected P = .02). The lower mean ALPS index was significantly associated with a worse Expanded Disability Status Scale score (Spearman ρ = -0.51; 95% CI, -0.85 to -0.02; P = .03). However, cortical volume and deep gray matter volume were not significantly different between the 2 groups, and they were not correlated with the Expanded Disability Status Scale.

CONCLUSIONS: This study suggests that patients with MOGAD may have impaired glymphatic function, as measured by the ALPS index, which is associated with patient disability. Further study is warranted with a larger sample size.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Hagiwara A, Tomizawa Y, Hoshino Y, et al. Glymphatic System Dysfunction in Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disorders: Association with Clinical Disability. AJNR Am J Neuroradiol. 2023. PMID: 38123957. doi:10.3174/ajnr.A8066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。